The College of American Pathologists has recently defined and introduced guidelines for clinical and laboratory evaluation of patients with monoclonal gammopathies (1) (2) (3) (4) . One of these guidelines states that all patients with multiple myeloma, Waldenströ m macroglobulinemia, amyloidosis, and related disorders should be assessed for the presence of urinary monoclonal free light chains by immunofixation electrophoresis (3 ) . Because free light chains are associated with more aggressive disease, the clinical relevance lies with the quantities of free monoclonal light chains excreted and not with the intact immunoglobulins, which also may be present in the urine (2, 5 ). Here we demonstrate that in some cases the intact immunoglobulins comigrate with the free light chains in immunofixation electrophoresis, and we provide a method to disclose this interference.
In the diagnostic work-up of a patient suffering from multiple myeloma, we performed immunofixation electrophoresis on serum and concentrated urine using a immunofixation reagent set (Beckman) with anti-human immunoglobulin antibodies (Dako), according to the manufacturer's protocol. Briefly, electrophoresis of 5 L of 1:10 diluted serum (2 L of serum plus 18 L of buffer) and 5 L of 50-fold concentrated urine was followed by immunofixation with 80 L of antiserum. Unprecipitated proteins were washed away before staining of the precipitated complexes with Amido black.
Immunofixation electrophoresis of our patient's urine revealed the same monoclonal pattern as was found in the patient's serum; an IgG heavy chain with the same mobility as the light chain (Fig. 1A, lanes 2 and 3) . However, there was an unexpected discrepancy between the IgG heavy chain and the light chain signal in favor of the latter.
To explore whether part of the light chain excess might be explained by the presence of free light chains, we used an immunosubtraction technique. We preincubated 10 L of the concentrated urine with 20 L of anti-IgG serum for 30 min at 37°C and centrifuged the mixture (15 min at 12 000g) before applying 5 L of the supernatant to the gel. The anti-IgG signal was not seen in the subsequent immunofixation. The anti-signal, however, was only partly affected by the immunosubtraction, indicating that free light chains indeed were responsible for part of the single monoclonal band in the electrophoretic pattern (Fig. 1A, lanes 5 and 6) . Fig. 1B shows immunofixation of the urine of a control patient, with free light chains and intact immunoglobulins migrating at different positions on the gel, demonstrating that heavy chain immunosubtraction affects only the intact immunoglobulins and not the free light chain signals. Preincubation with anti-IgA did not affect the anti-signal. Using this technique, we also identified more patients with a similar comigration phenomenon (Fig. 1C ).
Our results demonstrate that in immunofixation electrophoresis, free light chains indeed can be obscured by comigrating intact immunoglobulins. The presented immunosubtraction method provides a means to disclose this problem. Although the use of antibodies that specifically recognize only free light chains theoretically also can reveal such problems, reported problems with the sensitivities and specificities of such antibodies make results unpredictable and unsuitable for diagnostic use (1 ) . The method we describe here combines the specificity of immunosubtraction with the sensitivity of immunofixation, making it an attractive addition to the arsenal of laboratory tests for gammopathies in cases where there is Since 1961, the ⌬A 450 , or Liley, method has been used to estimate amniotic fluid (AF) bilirubin concentrations in RhD-alloimmunized pregnancies (1 ) . Although the results of this method often predict the degree of fetal anemia relatively well, blood-contaminated AF may give incorrect results (2, 3 ) Furthermore, with this method the AF bilirubin content is not expressed quantitatively as the bilirubin concentration.
As an alternative, a diazotization method has been used to measure the bilirubin concentration in AF (4 ) . Blood contamination could produce falsely increased bilirubin concentrations with this diazotization method, however, and this method is also considered to be inaccurate at the very low bilirubin concentrations in AF (3 ).
Recently we developed a procedure that uses a mathematic step-by-step (iterative) procedure to deconvolute the superimposed absorbance scans of pigments in cerebrospinal fluid into the scans of individual pigments. This iterative model is now in routine use for the spectrophotometric determination of methemoglobin (metHb), oxyhemoglobin (oxyHb), and bilirubin concentrations in cerebrospinal fluid (5 ) . The method is fast and simple, corrects for the relative interference of each of these components on the others, and has a lower limit of detection of 0.1 mol/L for each of these components. We suggest that, because of its high sensitivity, this method may become a reliable procedure to measure bilirubin concentrations in AFs.
AF was obtained after informed consent from patients [n ϭ 52; mean (SD) gestational age, 30.8 Ϯ 3.6 weeks] whose pregnancies were complicated by red cell alloimmunization. The fluids were centrifuged at 1400g for 10 min and were protected from light before analysis. Measurements were performed with a UltrospecPlus spectrophotometer (Amersham Pharmacia Biotech). For the Liley method, absorbance was measured at 365, 450, and 550 nm, and a baseline was estimated between 365 and 550 nm on a log-linear plot (with wavelength on the linear and absorbance on the log scale). The ⌬A 450 value was obtained by subtracting the baseline value (background) of the AF at 450 nm from that of the total absorbance at 450 nm. For the iterative method, AF was diluted with a one-tenth volume of phosphate buffer, pH 6.6 (5 ), and the absorbance was measured at 360, 405, 414, and 455 nm. Statistical analysis was performed with SPSS-10 (SPSS Inc.). The data are expressed as means (SD). P Ͻ0.05 was considered significant.
To measure the effect of background turbidity, Intralipid (Pharmacia &Upjohn) was used in the iterative model developed for cerebrospinal fluid (5 ) . As an alternative approach, we used a background baseline that corrects for the AF turbidity. The background correction was performed as for the Liley method, i.e., the baseline was estimated between 365 and 550. Subsequently, the absorbance at 360 nm was set to 1.0, and the absorbances at 405, 414, and 455 nm were converted into relative absorbance values. Within the original iterative model (5 ), the relative absorbances for Intralipid were 0.7627, 0.7260, and 0.5867, respectively, at 405, 414, and 455 nm with an absorbance of 1.0000 at 360 nm. The background turbidity differed substantially among the AFs and differed from that of Intralipid. When the relative absorbance was set to 1.0000 at 360 nm, the mean relative absorbance values for the 52 AF samples were 0.7163 (0.030) at 405 nm, 0.6691 (0.013) at 414 nm, and 0.4934 (0.043) at 455 nm. Correction for the effect of AF turbidity is thus essential. (The relative absorbance values for bilirubin were, respectively, 0.2214, 0.5801, 0.6921, and 1.000; for metHb they were 0.3012, 1.000, 0.6817, and 0.0695; and for oxyHb, they were 0.1993, 0.7689, 1.000, and 0.1125 (5 ) .
The effect of adding eight different amounts of exogenous bilirubin, metHb, and/or oxyHb on the native bilirubin concentrations was studied in 10 AF samples not contaminated with blood and with increasing Liley ⌬A 450 values (0.01-0.49). Bilirubin reference samples and metHb were obtained from Sigma Chemical. An oxyHb solution was prepared from residual donor erythrocytes. The concentrations of the oxyHb and metHb solutions were measured according to Feelisch et al. (6 ) . The final concentrations of the added bilirubin, metHb, and oxyHb were 0 -15 mol/L, with seven stepwise increases of ϳ2 mol/L. When the calculated bilirubin concentrations of the reference samples were plotted against the expected concentrations (0 -15 mol/L), we obtained a straight line with a slope of 0.98 and a y-intercept of 0.03 mol/L (r ϭ 0.998). For the hemoglobins, similar relationships were observed between the calculated and expected values.
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